Výsledky vyhledávání

Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease

Autor: Deepak Suri, S. Morgan, William Rosenberg, Douglas Thorburn, Julie Parkes, R. Gailer, Sudeep Tanwar, Ankur Srivastava, Emmanuel Tsochatzis, K. Sennett, Alison Rodger, P M Trembling

Publikováno v: Srivastava, A, Gailer, R, Tanwar, S, Trembling, P, Parkes, J, Rodger, A, Suri, D, Thorburn, D, Sennett, K, Morgan, S, Tsochatzis, E A & Rosenberg, W 2019, ' Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. ', Journal of Hepatology, vol. 71, no. 2 . https://doi.org/10.1016/j.jhep.2019.03.033

Background & Aims: the development of non-invasive liver fibrosis tests may enable earlier identification of patients with non-alcoholic fatty liver disease (NAFLD) requiring referral to secondary care. We developed and evaluated a pathway for the ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c72dc4b80677005a553669b3a986aa37
https://doi.org/10.1016/j.jhep.2019.03.033

Zobrazit plný text záznamu

Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease

Autor: R. Gailer, William Rosenberg, Anna Gola, S. Morgan, Sudeep Tanwar, Julie Parkes, K. Sennett, Emmanuel Tsochatzis, Simcha Jong, James O'Beirne, Ankur Srivastava, Elena Pizzo

Publikováno v: BMC Gastroenterology
BMC Gastroenterology, Vol 19, Iss 1, Pp 1-15 (2019)
BMC Gastroenterology, 19(1), 122

BackgroundThe identification of patients with advanced liver fibrosis secondary to non-alcoholic fatty liver disease (NAFLD) remains challenging. Using non-invasive liver fibrosis tests (NILT) in primary care may permit earlier detection of patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::678e52b64c2a7061b5b5dcb36364ed89
https://eprints.soton.ac.uk/432640/

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

M5 Developing improved models of care for COPD through partnership between a GP federation ‘quality improvement support team’ (QIST) and a consultant supported community respiratory service in an inner city borough

Autor: J Barlow, J Dzingai, J Lenders, A Williamson, E Jones, MJ Heightman, K Sennett

Publikováno v: Exploring airways disease.

Introduction and objectives Local integrated respiratory services are well developed with a successful primary care enhanced service scheme for COPD and commissioned integrated respiratory consultant roles. However, hospital admission data suggests s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::750ab4842aaa40f742601473cc6989d4
https://doi.org/10.1136/thorax-2018-212555.425

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

PWE-085 Analysis of new patient attendances for nafld at three london hospitals highlights the need to develop clinical risk stratification pathways

Autor: Deepak Suri, K. Sennett, D. Thorburn, S. Morgan, S Gulati, William Rosenberg, R. Gailer, Ankur Srivastava, A. Warner, Emmanuel Tsochatzis

Publikováno v: Gut. 64:A249.1-A249

Introduction 30% of the UK population has NAFLD. A significant minority (10%) will have NASH of whom 15% will develop cirrhosis. Recognising this subpopulation at risk can be difficult as patients are often asymptomatic. Non-invasive tests (NIT) of l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::113315422a3c8e3b1af64090d81a1c07
https://doi.org/10.1136/gutjnl-2015-309861.534

Zobrazit plný text záznamu

P223a Increasing the quality of COPD case finding, diagnosis and management through a primary care financial incentive scheme in inner London

Autor: M Calonge Contreras, K Sennett, L Restrick, C Cooper, J Billett, M Stern

Publikováno v: Thorax. 66:A159-A159

Introduction and Objectives COPD is a major cause of mortality/morbidity in high smoking prevalence Primary Care Trusts (PCTs). Our PCT expected COPD prevalence (3.7%) is therefore high but recorded prevalence (2009/2010) was 1.4%, suggesting large n

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c56b65a5d26c67ce4bcff1dff7e29f32
https://doi.org/10.1136/thoraxjnl-2011-201054c.223a

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání